CORDA Investment Management LLC. lessened its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 1.7% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 420,154 shares of the company

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund trimmed its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 21.3% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fu

Mosaic Family Wealth Partners LLC raised its position in Merck & Co., Inc. (NYSE:MRK - Free Report) by 154.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,904 shares of the company

Meridian Wealth Management LLC increased its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 11.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 79,604 shares of the company

Russell Investments Group Ltd. boosted its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 2.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,578,024 shares of the company

ANTIPODES PARTNERS Ltd decreased its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 23.9% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,097,509 shares of the company

Moran Wealth Management LLC lowered its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 3.7% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 212,218 shares of the company

Mitsubishi UFJ Trust & Banking Corp raised its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 8.9% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,727,562 shares of the company

Merck & Co. stock has pushed to a new 52-week high in August 2026 as investors digest positive Phase

HighTower Advisors LLC grew its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 1.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,679,920 shares of the company

Janney Montgomery Scott LLC lowered its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 1.4% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,655,632 shares of the company

Midwest Trust Co decreased its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 1.2% during the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 738,473 shares of the company

KBC Group NV reduced its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 7.1% in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 1,131,286 shares of the company

USA Financial Formulas purchased a new stake in Merck & Co., Inc. (NYSE:MRK - Free Report) during the first quarter, according to its most recent filing with the SEC. The fund purchased 7,410 shares of the company

Fifth Third Bancorp reduced its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 2.8% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,500,619 shares of the company

Donaldson Capital Management LLC grew its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 1.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 798,673 shares of the company

Delivers cutting-edge commentary on important legal issues affecting health care and life sciences institutions.